STACIE NELSON: Open Payments
NPI 1164518502 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 12 payments from 7 companies in 2025. Trend: 2023 $394 · 2024 $331 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $58 |
| PFIZER INC. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Novo Nordisk Inc | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Medtronic, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, Ozempic, VELSIPITY, AIRSUPRA, VENASEAL, NURTEC ODT, GVOKE HYPOPEN.
Industry payments across TX — which companies pay providers there.
